A Research Study Examining the Use of Olanzapine for the Prevention of Migraine

NCT00203307 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Study terminated by sponsor

Conditions

Migraine

Interventions

DRUG: Olanzapine during first intervention period and placebo during second intervention period
DRUG: Placebo during first intervention period, then olanzapine during second intervention period

Sponsor

Thomas Jefferson University

Collaborators

[object Object]